Psychedelic therapy gets personal: music or mindfulness for depression?
NCT ID NCT07373535
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether tailoring psilocybin-assisted therapy to a person's preferences (music or mindfulness) is practical and helpful for treatment-resistant depression. Sixteen adults will receive two doses of psilocybin, each paired with a different therapy style, to see if matching the approach to their preference improves mood and well-being. The goal is to learn how to make this promising treatment more effective and personalized.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
Jewish General Hospital
Montreal, Quebec, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which works best for stubborn depression? adding a drug, brain stimulation, or switching meds?
- Fast brain stimulation shows promise for stubborn depression
- Ketamine booster for shock therapy? new trial aims to lift depression and protect memory
- Could an arthritis drug lift the fog of Treatment-Resistant depression?
- Can a gentler brain stimulation replace ECT for tough depression?
- Can ketamine plus therapy curb suicidal thoughts? new trial aims to find out.